Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 24, 2010
The timing of surgery for resectable metachronous liver metastases from colorectal cancer: Better sooner than later? A retrospective analysisMario Scartozzi, Walter Siquini, Eva Galizia, et al.Current Oncology Reports|April 29, 2010
Novel perspectives for the treatment of gastric cancer: from a global approach to a personalized strategyMario Scartozzi, Mirco Pistelli, Alessandro Bittoni, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expressionMario Scartozzi, Francesca Bianchi, Saverio Rosati, et al.European Journal of Human Genetics : EJHG|May 26, 2006
Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional featuresLaura Belvederesi, Francesca Bianchi, Cristian Loretelli, et al.Cancer Chemotherapy and Pharmacology|September 8, 2010
Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trialStefano Cascinu, Eva Galizia, Roberto Labianca, et al.Familial Cancer|December 14, 2006
A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-ItalyFrancesca Bianchi, Eva Galizia, Emilio Porfiri, et al.Analytical and Quantitative Cytology and Histology|August 13, 2010
BRCA1 expression in triple negative sporadic breast cancersEva Galizia, Gessica Giorgetti, Gina Piccinini, et al.Plos One|July 19, 2012
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patientsMario Scartozzi, Cristian Loretelli, Eva Galizia, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 7, 2011
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patientsMario Scartozzi, Cristian Loretelli, Rossana Berardi, et al.The Oncologist|January 8, 2011
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximabMario Scartozzi, Alessandra Mandolesi, Riccardo Giampieri, et al.Pageof 3